Exercise in multiple sclerosis and its models: Focus on the central nervous system outcomes

J Neurosci Res. 2020 Mar;98(3):509-523. doi: 10.1002/jnr.24524. Epub 2019 Sep 4.

Abstract

Multiple sclerosis (MS) is a central nervous system (CNS) disorder characterized by inflammation, demyelination, and neurodegeneration. Emerging research suggests that exercise has therapeutic benefits for MS patients but the clinical data have focused primarily on non-CNS outcomes. In this review, we discuss evidence in preclinical MS models that exercise influences oligodendrocyte proliferation and repopulation, remyelination, neuroinflammation, neuroprotection, axonal regeneration, and astrogliosis. Evidence for the therapeutic effects of exercise in MS is further supplemented by data from other CNS diseases, including Alzheimer's disease, Parkinson's disease, and spinal cord injury. These results motivate studies into the benefits that exercise confers within the CNS in MS.

Keywords: neuroinflammation; neuroprotection; oligodendrocytes; physical activity; remyelination.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Disease Models, Animal
  • Encephalitis / physiopathology
  • Encephalitis / prevention & control
  • Exercise Therapy*
  • Humans
  • Multiple Sclerosis / physiopathology*
  • Multiple Sclerosis / prevention & control*
  • Oligodendroglia / physiology
  • Physical Conditioning, Animal
  • Remyelination
  • Translational Research, Biomedical

Grants and funding